Skip to main content
. Author manuscript; available in PMC: 2017 Jan 15.
Published in final edited form as: Hum Mutat. 2016 Oct 7;38(1):7–15. doi: 10.1002/humu.23128

Table 1.

Potential Therapeutic Approaches Currently Being Investigated

Mode of action Stage References
p38 MAPK inhibitor Inhibition of p53 pathway and SASP In vitro [Davis et al., 2005; Davis et al., 2016; Tivey et al., 2013]
mTOR inhibitor Stimulation of autophagy In vitro [Saha et al., 2014; Talaei et al., 2013]
Vitamin C Reduction of ROS In vitro [Aumailley et al., 2015a; Kashino et al., 2003; Li et al., 2016]
Astaxanthin Reduction of ROS In vivo [Takemoto et al., 2015]
PTC read-through Bypassing nonsense mutation In vitro [Agrelo et al., 2015]
Stem cell gene therapy Gene editing of stem cells In vivo [Cheung et al., 2014; Shimamoto et al., 2014; Shimamoto et al., 2015; Zhang et al., 2015]